Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.

Translated title of the contribution: Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.

L.F. van Gaal, A.J. Scheen, H.P.F. Koppeschaar, Study Group RIO-Europe, C. Hanotin, O. Ziegler

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionLong-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.
Original languageUndefined/Unknown
Pages (from-to)1761-1771
Number of pages11
JournalEuropean Heart Journal
Volume29
Issue number14
Publication statusPublished - 2008

Cite this